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1. Introduction 
Schizophrenia affects about 0.5-1.0% of people worldwide, occurring roughly equally in 
both men and women. The exact causes of schizophrenia are not fully understood, although 
the consensus of current research is that schizophrenia is a developmental disorder, caused 
by a genetic liability interacting with environmental and psychosocial stress. However, the 
possible neurobiological mechanisms underlying this  gene-stress interaction are largely 
unknown.   
To study the role of stress in the development of schizophrenia, it is useful to dissect this 
complex disease into specific symptoms. In this respect, a well-accepted model for 
psychotic-like behavior is prepulse inhibition (PPI) of the startle response. In an attempt to  
clarify  the link between stress and schizophrenia, this chapter reviews experimental studies 
that determined the effect of  acute and chronic stressors on PPI in humans and rodents. In 
section 2, studies that have focused on stress in adulthood will be discussed, and in section 
3, studies that have addressed effects of early-life stress on PPI will be outlined. Together, 
the findings of these PPI studies support the  neurodevelopmental theories of schizophrenia, 
which state that insults, including stress, experienced during early brain development could 
particularly increase the risk of developing schizophrenia.   
1.1 Symptom dimensions in schizophrenia 
Schizophrenia is a mental disorder, characterized by a mixture of symptoms that are 
generally divide into three major clusters: positive, negative, and cognitive symptoms (APA, 
2000). The first category signifies symptoms that reflect excess in normal function, which 
comprises psychotic symptoms. These mental phenomena are often dramatic; the patient 
appears to have lost contact with reality. Hallucinations are one type of positive symptom; 
they are perceptions disconnected from external stimuli, which may occur in any sensory 
modality, however, auditory hallucinations (i.e. hearing voices) are the most common 
hallucinations in schizophrenia. Delusions are another type of positive symptom, which are 
fixed, false beliefs that are not shared by other people in the patient’s neighborhood. The 
most common form is the paranoid delusion, such as the false belief that one is spied on, or 
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being persecuted. However, a variety of other themes is also possible, for instance the belief 
that the fillings in one’s teeth are radio transmitters receiving extraterrestrial messages, or 
the belief that some outside agency has added or removed thoughts in one’s brain.  
Negative symptoms, on the contrary, describe loss or significant impairment of normal 
psychological functions, such as blunted affect, emotional withdrawal, poor rapport, 
passivity and apathy, and anhedonia (APA, 2000). Although this reduction in normal 
functioning may seem less dramatic as positive symptoms, particularly negative symptoms 
are associated with long periods of hospitalization and poor social functioning. Indeed, a 
patient’s degree of negative symptoms appears to determine whether a patient is still able to 
function in society. Last, cognitive symptoms of schizophrenia comprise ‘executive 
dysfunctions’, including problems in maintaining goals, allocating attentional resources, 
evaluating and monitoring performance, and utilizing these capacities to solve problems.  
1.2 Diathesis-stress hypothesis of schizophrenia 
Schizophrenia is a complex illness, and its possible causes are still subject of debate. 
However, according to a widely adopted view, both a biological predisposition, and 
exposure to environmental stress are necessary ingredients for schizophrenia to become 
manifest – the so-called diathesis stress model (Zubin & Spring, 1977). A classical example of 
the association between environmental stress and the risk of developing schizophrenia, 
comes from studies of the 1944-1945 Dutch Hunger Winter (Susser & Lin, 1992; Susser et al., 
1996; Susser et al., 1998). In this discrete period during the Second World War, there was a 
serious decline in food intake in six cities of western Netherlands. Among people born in 
these cities between 1944 and 1946, the most exposed birth cohort (i.e., conceived at the 
height of the famine) showed a twofold and statistically significant increase in the risk for 
developing schizophrenia (Susser & Lin, 1992). Since this particular famine, many others 
occurred worldwide, but these were less suitable for epidemiological investigations due to 
more disorganized conditions (St Clair et al., 2005). However, several years after the Dutch 
Hunger Winter, a similar occasion occurred in China. Specifically, from 1959-1961, people in 
affected provinces were starving and died in large numbers due to bad weather (for refs see 
(St Clair et al., 2005)). Among births that occurred during the famine years, the risk of 
developing schizophrenia in later life was significantly increased when compared to those 
born before or afterwards (St Clair et al., 2005).  
These ‘natural experiments’ suggest that prenatal stress, i.e., exposure to maternal 
nutritional deficiency, could increase the risk of schizophrenia in later life. However, 
evidence from many observational studies that have investigated the association between 
experience of stress in adulthood and acute onset of psychotic illness, has not been 
confirmative (Phillips et al., 2007). In particular, there is no consistent evidence that 
experience of stressful life events is able to trigger onset of psychosis. Findings from 
longitudinal studies on the other hand, are stronger in linking episodes of relapse in 
schizophrenia patients to an elevated rate of stressful life events (Phillips et al., 2007; Walker 
et al., 2008), thus providing additional evidence for a role of stress exposure in (the course 
of) schizophrenia.  
1.3 Neurodevelopmental hypothesis of schizophrenia 
As mentioned earlier, schizophrenia is generally not diagnosed before the third decade of 
life, suggesting that it is the end point of some pathological process acting on the immature 
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brain. This observation has led to the formulation of the neurodevelopmental hypothesis of 
schizophrenia, which states that environmental disturbances during early brain 
development influence risk of developing schizophrenia (Harrison, 1997; Rehn & Rees, 2005; 
Fatemi & Folsom, 2009).  Some candidates for these early disturbances are, for instance, 
prenatal influenza exposure, obstetric complications, prenatal maternal psychological stress, 
maternal and fetal nutritional deficiency, season of birth (for refs, see (St Clair et al., 2005)). 
However, obviously, not every individual will get ill if they experience stress. Consequently, 
it is thought that manifestation of disease originates through an interaction with the genetic 
make-up of an individual (Harrison, 1997; Rehn & Rees, 2005; Fatemi & Folsom, 2009).  
Several lines of evidence support the neurodevelopmental hypothesis, including 
epidemiological studies, premorbid history and neuropathological postmortem studies 
(Fatemi & Folsom, 2009). With respect to genetics, many susceptibility genes, found to be 
associated with a heightened risk for developing schizophrenia, have been linked to 
neurodevelopmental processes, such as synaptic connectivity, synaptogenesis, and growth 
factors (Stahl, 2008).  
However, a remaining question is, whether one single intervention early in development is 
enough to explain occurrence of schizophrenia much later in life. An alternative hypothesis, 
that works within the framework of the neurodevelopmental theory, is referred to as the 
double-hit model (Keshavan & Hogarty, 1999; Keshavan, 1999; Maynard et al., 2001). 
According to this model, maldevelopment within 2 critical windows of vulnerability 
combines to lead to clinical manifestations of schizophrenia. First, early developmental risk 
factors (i.e. genetic predisposition, environmental stressor) will cause a heightened 
vulnerability to the illness through anomalous neural development and subtle changes in 
behavior. However, for schizophrenia to become manifest, an additional second hit (i.e.  an 
environmental factor such as drug abuse or social stress) is considered necessary. Thus, in 
this view, early and late risk factors are not simply additive, but instead, the first hit will 
increase an individual’s vulnerability for effects of a subsequent hit (Keshavan & Hogarty, 
1999; Keshavan, 1999; Maynard et al., 2001). 
1.4 Prepulse inhibition of the startle response 
In order to test the above-mentioned theories, animal models could be used. However, due 
to the nature of the symptoms and the pathological complexity of schizophrenia, it is 
impossible to reproduce the disease in its entirety in an animal model. As a possible 
solution, one could model specific aspects or symptoms of the disorder. A highly validated 
model in this respect is the behavioral paradigm of prepulse inhibition (PPI) of the acoustic 
startle response, which is typically, but not exclusively, diminished in schizophrenic 
patients (Braff et al., 2001a; Geyer et al., 2001; Swerdlow et al., 2001; Swerdlow et al., 2008). 
As disrupted PPI is a trait marker of schizophrenia, which is also displayed by patients’ 
unaffected relatives, as well as schizotypal (i.e., non-psychotic, unmedicated) patients, 
impaired sensorimotor gating is considered an endophenotype of schizophrenia (Braff et al., 
2008).  
PPI refers to the normal suppression of a startle response to a strong stimulus when it is 
preceded by a weaker stimulus (the prepulse). In rodents, PPI is commonly measured as 
whole-body startle responses, whereas in human experiments, generally eye-blink 
responses are used. In theory, deficient PPI in schizophrenic patients  reflects a dysfunction 
in the gating of sensory and cognitive information, clinically manifesting as a patient’s 
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inability to filter irrelevant thoughts and sensory stimuli from intruding into awareness 
(Braff et al., 1978; Braff et al., 2008). Some cross-sectional and longitudinal studies 
demonstrate that in patients, deficits in sensorimotor gating are improved by atypical 
antipsychotics (Swerdlow et al., 2008; Aggernaes et al., 2010). Neurophysiologically, PPI is 
mediated via the brainstem, whereas it is regulated by an extensive set of interrelated 
projections from the forebrain (Swerdlow et al., 2001). Pharmacological interventions that 
diminish PPI are well characterized in animal models (Geyer et al., 2001) and also 
increasingly applied in healthy human subjects (Braff et al., 2001b; Oranje et al., 2004; Jensen 
et al., 2007; Oranje et al., 2011). In particular, PPI is disrupted by dopamine receptor agonists 
(e.g., apomorphine), serotonin receptor agonists (e.g., 8-OHDPAT), and NMDA receptor 
antagonists (e.g., PCP). Accordingly, the different models of disrupted PPI have been used 
in the search of novel antipsychotic treatments, and each of the models has proven to be 
sensitive to at least some antipsychotic medications (Geyer et al., 2001). Notably, concerning 
interventions in the dopaminergic system, application of receptor agonists into the 
(subcortically located) nucleus accumbens and receptor antagonists in the medial prefrontal 
cortex diminish PPI (Wan & Swerdlow, 1993; Ellenbroek et al., 1998), providing considerable 
construct validity to PPI as a model for deficient sensorimotor gating in schizophrenic 
patients. Thus, PPI is considered a robust, predictable and neurobiologically informative 
experimental measure, broadly used in translational models for schizophrenia research. 
While PPI is largely determined by anatomical and genetic traits (Swerdlow et al., 2008), it 
may also be sensitive to effects of stress – which may be even more relevant, considering the 
leading theories on the development of schizophrenia. Therefore, the aim of this chapter is 
to explore the studies that applied experimental stressors to investigate their influence on 
PPI.  
2. Adult stress and gating mechanisms: Evidence from animal and human 
studies 
2.1 Effects of acute stress on sensorimotor gating: Animal studies 
In this section, we will review the existing literature on the effects of acute and chronic stress 
on PPI in adult rodents. For this purpose, some studies have pharmacologically interfered 
with a neural system that is fundamental to the biological stress response in mammals, the 
hypothalamic-pituitary-adrenal (HPA) axis, as discussed in section 2.1.1. Alternatively, 
external stressors have been artificially applied to rodents in the laboratory. In general, these 
stressors can be classified as either physical (i.e., nociceptive) or psychological, which will be 
outlined in sections 2.1.2. and 2.1.3., respectively.  
2.1.1 HPA modulators 
In a straightforward approach to address the link between stress in adulthood and PPI, 
some studies have pharmacologically interfered with the HPA axis, a major mammalian 
stress system. Physiologically, the function of the HPA-axis is to transduce neural signals 
that arise in response to any physical or psychological stressor, into an endocrine response; 
starting at the level of the brain’s major integrating center: the hypothalamus. In this 
structure, the neuropeptide corticotrophin-releasing factor (CRF) is produced. When CRF is 
released into the hypophyseal portal system, it travels to the pituitary gland, where it binds 
to CRF1 receptors. This, in turn, triggers the secretion of adrenocorticotropic hormone 
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(ACTH). Subsequently, ACTH is transported via the systemic circulatory system to the 
cortex of the adrenals, where it triggers the release of glucocorticoids. Through a negative 
feedback at the level of the hypothalamus and pituitary, glucocorticoids (cortisol in primates 
and corticosterone in rodents) ultimately inhibit their own release. For decades, the HPA-
axis has been linked to schizophrenia (Yeap & Thakore, 2005; Phillips et al., 2006; Phillips et 
al., 2007; Walker et al., 2008). Notable findings in patients are elevated cortisol levels, 
especially shortly before onset of psychosis (reviewed by Walker & Diforio, 1997; Walker et 
al., 2008), and altered stress responsiveness, with cortisol responses being both enhanced 
(Walker et al., 2008) and blunted (Brenner et al., 2009; van Venrooij et al., 2010).  
Some experimental animal studies have investigated the influence of HPA-axis 
manipulations on PPI. For instance, Van den Buuse and co-workers investigated the effects 
of a dopaminergic D2 receptor antagonist (i.e. haloperidol) on the PPI response in mice 
following adrenalectomy and corticosterone replacement (2, 10 or 50 mg) (van den Buuse et 
al., 2004). Subsequently, the animals were tested for PPI after injection of haloperidol. In 
adrenal-intact mice and in mice implanted with 10 mg corticosterone, haloperidol treatment 
increased PPI, while in both the 2 and 50 mg corticosterone-adrenalectomy groups, PPI was 
unchanged. The authors explained their results by postulating a corticosterone-dopamine 
interaction; moderate levels of corticosterone would be needed for a normal dopaminergic 
tone, while both low and high concentrations of corticosterone would induce reductions in 
dopaminergic activity (Van den Buuse et al., 2004). Indeed, an interaction between 
corticosteroids and central mesolimbic dopaminergic activity is suggested by several studies 
(Piacentini et al., 2004; Pruessner et al., 2004; Marinelli et al., 2006). 
At the level of CRF, intraventricular brain injections with the neuropeptide lead to reliable 
alterations in PPI. This is not surprising, given  the putative involvement of CRF in stress 
disorders and psychosis (Nemeroff et al., 1984; Charney et al., 1993; Sautter et al., 2003; 
Herringa et al., 2006) and the fact that CRF receptors are expressed in areas that modulate 
startle and PPI, including brainstem, limbic and cortical nuclei (Van Pett et al., 2000). In 
rodents, both acute central administration of CRF (Conti et al., 2002; Risbrough et al., 2004; 
Conti, 2005; Bakshi et al., 2011) and chronic CRF overexpression (Dirks et al., 2002) diminish 
PPI. However, unlike central CRF, peripherally injected CRF at doses that are known to 
cause the release of ACTH and corticosterone, did not reduce PPI in rats (Conti, 2005). 
Consequently, it was suggested that the effect of central CRF on PPI might be independent 
of its effects on the HPA axis. This finding is in agreement with a study of Groenink et al. 
(2008), which showed that neither glucocorticoid receptor antagonists nor adrenalectomy 
did improve perturbation of PPI in mice overexpressing CRF (CRF-OE mice). In addition, 
elevation of corticosterone levels by pellet implantation did not affect PPI in wild-type mice. 
In contrast, two different CRF1 receptor antagonists significantly restored PPI in CRF-OE 
mice, based on which the authors concluded that chronic overactivation of CRF1 receptors 
rather than excessive glucocorticoid receptor stimulation underlies PPI deficits in CRF-OE 
mice. Also in rats, neither acute, nor repeated administration of corticosterone decreased PPI 
(Czyrak et al., 2003). In the brain, CRF acts via CRF1 and CRF2 receptors. Risbrough et al. 
(2004) investigated the respective roles of these two receptor subtypes in the startle response 
and sensorimotor gating in mice. Regarding the magnitude of startle, they found that CRF1 
receptors are required for the effects of CRF, and CRF2 receptors appear to have an auxiliary 
role. Furthermore, CRF1 receptor blockade reversed CRF-induced deficits in PPI, whereas 
CRF2 receptor blockade potentiated the latter effect. In addition, CRF2 receptor activation 
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increased PPI. Together, as was argued, these findings support the idea that CRF1 and CRF2 
receptors exert opposing roles in inhibition of startle, with CRF1 decreasing PPI and CRF2 
increasing it. Thus, the effect of central CRF on PPI is probably not mediated by 
corticosterone. However, as was mentioned before, corticosteroids could play a role in 
regulating PPI via an interaction with mesolimbic dopaminergic activity.   
2.1.2 Physical stressors 
From animal models, it has long been known that intermittent and inescapable foot-shock 
can induce a state of analgesia (stress-induced analgesia), which is reversed by the opiate 
receptor antagonist naloxone (Madden et al., 1977).  Functionally, this anticipation response 
to upcoming aversive stimuli reduces their impact and is thought to help the organism cope 
with the stressor (Willer & Ernst, 1986). To examine whether exposure to a severe stressor 
induces changes in sensory functioning that accompany stress-induced analgesia, Leitner 
and co-workers measured PPI in rats shortly (i.e., 20 min) after exposure of cold swim stress 
(Leitner, 1986). Next to a reliable analgesia, the stressed animals exhibited decreased 
prepulse inhibition. In a subsequent study, this stress-induced PPI-deficit appeared to be of 
a multisensory nature, as reductions in PPI were found in reaction to both visual and 
acoustic prepulse stimuli (Leitner, 1989). The author interpreted these results as a general 
decrease in sensory sensitivity, which extends beyond the noxious stimulus (i.e., cold 
water). The finding supports a possible role for opiates in the PPI-disruptive effect of 
analgesia, in that opioid receptor agonists, which produce perceptual distortions in animals 
and humans, disrupt PPI in a dose-dependent fashion (Bortolato et al., 2005). However, 
another nociceptive stressor, i.e., repeated inescapable foot-shocks, slightly increases PPI 
(Pijlman et al., 2003), or has no effect (Bijlsma et al., 2010; Bakshi et al., 2011). Possibly, these 
conflicting findings can be partly explained by the longer stress-test intervals applied in the 
latter studies (see table 1). Lastly, the physical stressor referred to as restraint stress, 
comprises physically restraining a rodent in a narrow cylinder, usually for 15-20 minutes, 
sometimes on several subsequent days. Restraint stress has been shown to increase plasma 
ACTH, beta-endorphin, and corticosterone levels, and also brain levels of serotonin and 
norepinephrine (for refs, see (Acri, 1994)). However, the studies that examined the effects of 
restraint on PPI, have mostly reported inconsistent, or no effects of restraint (Acri, 1994; 
Faraday, 2002; Bijlsma et al., 2010), and one study showed that repeated, but not acute, 
restraint stress decreased PPI (Sutherland & Conti, 2011).  
Thus, studies that have applied physical stressors in adult rodents have yielded inconsistent 
or no effects on PPI (table 1.a.). However, although some of these artificial stressors have 
been shown to be capable of producing elevated levels of stress hormones, the ethological 
validity of these stressors is not very high. In the next section, studies that examined the 
influence of ethologically more relevant psychological stressors will be discussed.  
2.1.3 Psychological stressors 
As opposed to physical stress, psychological stress does not involve a nociceptive 
component, as physical contact with the stressogenic stimulus is absent. This can be 
accomplished in several ways. One particularly simple method to induce emotional stress 
involves forcing rats to witness another rat being exposed to physical stress, such as 
repeated foot-shocks, or restraint. This observational stressor has been found to activate 
mesocortical dopamine systems (Kaneyuki et al., 1991). However, it is also proposed to 
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represent a milder form of stress, as plasma corticosterone levels were found to be less 
elevated, compared to the concomitant physical stress condition (Acri, 1994). Studies that 
examined sensorimotor gating following witness stress, have reported no effects on PPI 
(Acri, 1994; Pijlman et al., 2003).  
Another psychological stressor, that is considered more potent, is referred to as social defeat. 
In this paradigm, an animal is made an intruder, by placing it into the residential cage of an 
aggressive conspecific, where it is attacked, though, generally, the experimenter will protect 
it from suffering too much physical harm. After a few minutes, the intruder is placed in a 
small cage within the resident’s cage. As a consequence, it is not exposed to further injuries 
and direct attacks, but still remains in an unfamiliar environment, with olfactory, visual and 
to some extent physical (only via vibrissae) contact with the resident. Social defeat may have 
some face validity with respect to schizophrenia, as high levels of social competition and 
migration are proposed as risk factors for developing schizophrenia (Selten & Cantor-Graae, 
2007). In rodents, social defeat has been associated with dopaminergic hyperactivity and to 
behavioral sensitization, whereby the animal displays an enhanced response to dopamine 
receptor agonists (Selten & Cantor-Graae, 2007). With respect to PPI, significant 
impairments in the response were found following 3 weeks of daily social defeat in adult 
mice, which could be normalized by acute treatment with the cannabinoid receptor agonist 
WIN55212.2 (Brzozka et al., 2011).  
Another ethologically valid psychological stressor involves exposure to a predator. Next to 
foot-shock stress (see section 2.1.2), Bakshi and co-workers also exposed their rats to ferrets, 
one of their natural predators (Bakshi et al., 2011). To make sure that the stressor would be 
entirely psychogenic, the rats were protected from injury by a protective cage. This kind of 
predator exposure has been shown to elicit acute HPA axis  activation, freezing behavior 
and ultrasonic vocalizations (for refs, see Bakshi et al., 2011). When compared to foot-shock 
stress, predator exposure was found to be equipotent in terms of the amplitude of acute 
corticosterone release. However, foot shock stress had no effects on PPI at any measured 
time-point, while predator exposure significantly disrupted PPI at 24 hours after the stress; 
but not acutely, or 48 hours, or 9 days later (Bakshi et al., 2011).  
In our laboratory, we examined the influence of psychological stress, i.e., the potential threat 
of bright light, on PPI in Wistar rats. In rodents, high illumination potentiates startle (light-
enhanced-startle, LES), an anxiety response sensitive to clinically effective anxiolytics (de 
Jongh et al., 2002). As shown in figure 1, exposure to bright light significantly reduced PPI, 
whereas subsequent return to the safe condition enhanced PPI (for details see figure legend). 
These changes were most marked at lower prepulse intensities (interaction effect of prepulse 
intensity*phase F 4, 80=4.57, p<0.005).  
Schmajuk and co-workers also reported diminished PPI induced by dark-to-light 
transitions, an effect that was blocked by haloperidol (Schmajuk et al., 2009). However, in 
addition to PPI, the animals also showed attenuated startle, which indicates that the (lower) 
illumination conditions used in the Schmajuk study did not induce anxiety. Accordingly, 
the authors explained their findings by stating that sudden changes in environment 
illumination (i.e. novelty) may evoke dynamic changes in dopaminergic circuits that 
modulate the startle response and prepulse inhibition (Schmajuk et al., 2009).  
In conclusion, the currently available studies, although limited, demonstrate that 
psychological stress can indeed affect PPI (table 1.b.). However, results are not unequivocal. 
Due to considerable variation in duration and time course of effect, it is unclear how long 
the PPI-disruptions will last, once the stressors are terminated, and further studies are 
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warranted to assess time-course and robustness and underlying mechanism involved in the 
observed alterations in gating mechanisms. 
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Fig. 1. PPI was measured under light-enhanced-startle conditions, with subsequent return to 
the dark (N=22). The test procedure was modified from de Jongh et al. (2002), and consisted 
of three phases. During phase 1 and 3 rats were tested in the dark, whereas during phase 2 
the test cubicle was brightly lit (900 lux). Following a 5-min acclimatization period, each 
phase started and ended with five pulse alone trials. In between, five different trials were 
presented 10 times each: pulse alone (115 dB, 50 ms duration), pulse preceded by a 20 msec 
prepulse of either 74, 78 or 86 dB and no-stimulus trials, average inter trial interval 15 s.  
Shown is percent PPI (mean + S.E.M.) in safe (black bars) and threat (open bars) conditions. 
Potential threat (i.e. bright light) significantly reduced PPI, and subsequent return to the safe 
(i.e. dark) condition significantly enhanced PPI. * P < 0.05.  
2.2 Effects of acute stress on sensorimotor gating: Human studies 
In section 2.1. we have explored studies that investigated the influence of transient stress on 
the rodent PPI response. In the next sections, studies on human subjects are discussed, 
where stress has also been found to affect PPI. For instance, in a recent study, intravenous 
infusions of cortisol, in a dose resembling the physiological cortisol secretion in response to 
a moderate stressor, were shown to disrupt PPI in healthy participants (Richter et al., 2010). 
The disruptions reached a maximum at 20 minutes after administration, and returned to 
baseline another 20 minutes later. In an older study, Grillon and Davis investigated effects 
of stress and shock anticipation on PPI and startle in healthy subjects (Grillon & Davis, 
1997). Basically, they measured PPI both when the subjects anticipated shocks (i.e. the threat 
condition) and when no shocks were anticipated (i.e. the safe condition). The authors argued 
that the fear induced by the threat condition would be superimposed on a generally 
stressful experience of the experiment. To distinguish effects of general alertness, they 
added a nonadversive control condition with a different group of participants. In this 
control experiment, participants were asked – and being paid for – to keep attention to 
auditory, visual and tactile stimuli in the test environment. As a result, both shock 
anticipation (i.e. fear) and attention to external stimuli significantly increased PPI. 
Regarding the increased PPI in the fear condition (later replicated by (Cornwell et al., 2008)), 
the authors suggested that threat of shock may have increased the general level of alertness, 
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which facilitates the processing of stimuli, thereby enhancing the effectiveness of the 
prepulse in inhibiting the startle response.  
Repeated periods of shock anticipation however, were found to diminish PPI, an effect that 
was hypothesized to represent a progressive deficit in sensory functioning due to the 
prolonged stress of repeated shock anticipation. Apparently, this finding is not in agreement 
with animal work, where foot-shock stress had no effect on PPI (section 2.1.2). However, an 
important difference between human shock anticipation and the animal foot-shock 
paradigm is the physical component of the stress: during the entire experiment, human 
subjects only received a single shock, while animals were repeatedly exposed to shocks. In 
other words, the human threat-of-shock paradigm generally represented the psychological 
stress of potential threat, while the animal foot-shock stress had a large physical component 
of actual shocks, which might be less powerful. In this view, the human findings are 
consistent with the animal studies of (potential) threat, where diminished PPI was induced 
by the potential threat of bright light, and by the threat of predation (section 2.1.3.).   
2.3 Effects of acute stress on sensory gating: Human studies 
In addition to PPI, the brain’s pre-attentive inhibitory functions are evaluated by an 
electrophysiological response-reduction paradigm, which is a paired-click test, wherein 
the P50 (or P1) wave of the vertex auditory event-related potential (i.e. computerized 
averages of the brain’s electrical response to sound) is recorded. In healthy subjects, the 
P50 response to the second stimulus is generally attenuated (i.e. sensory gating), whereas 
in patients with schizophrenia and other psychiatric illnesses it is not suppressed (Adler 
et al., 1982; Adler et al., 1994), indexing deficits in filtering out irrelevant sensory stimuli 
(White & Yee, 1997). Like PPI, auditory sensory gating is influenced by stress. Note, that 
although the two experimental measures of brain inhibitory function are related, they are 
not identical in every respect, and partly regulated by different brain structures (Braff et 
al., 2001a). However, the fact that PPI and P50 gating are both measures of sensory gating 
that are influenced by stress, may point to possible common sources of functioning within 
the brain. 
A few studies have reported decreased sensory gating following a stressful intervention. 
Effects of cold stress have been evaluated by the cold-pressor test, in which subjects have to 
submerge a hand to the wrist in cold water for a fixed period. To control for successful stress 
induction, subjective distress and arterial blood pressure were measured. With respect to 
PPI, the studies reported transient but significant deficits in response to cold stress, in 
addition to increased distress ratings and higher systolic arterial tension (Johnson & Adler, 
1993; Ermutlu et al., 2005).  Brief psychological stress has been found to exert similar effects. 
In a study by White and Yee (1997), subjects were administered an oral arithmetic task; this 
mentally stressful task resulted in reduced P50 suppression in the participants. Possible 
effects of attention were ruled out by adding an equally difficult, but non-stressful 
arithmetic task, which did not affect P50 suppression. 
2.4 Conclusion section 2 
In table 1.a. and 1.b., an overview is given of studies reporting on effects of acute stressors in 
adult life on measures of sensory gating. Available evidence, from both animal and human 
subjects, indicates that acute stress can modify sensory gating. However, underlying 
neurobiological mechanisms remain poorly understood. Possibly, in first instance, moderate 
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threat or attention to the environment could facilitate processing of sensory stimuli, for 
instance, via increased cortical arousal. Indeed, substantial evidence confirms that directing 
attention to the prepulse signal enhances PPI in humans and, likewise, emotional learning 
has been shown to enhance PPI in rats (reviewed by Li et al., 2009a).  Severe or prolonged 
stressors on the contrary, may cause (progressive) loss of sensory perception that functions 
to reduce the impact of impending aversive events (Grillon & Davis, 1997). Particularly, 
these perceptual changes may be mediated by cortisol and CRF-induced activation of the 
mesolimbic dopamine system, a neural circuitry implicated in both stress responsivity and 
PPI.   
However, some studies do not find an effect at all. From the animal work under review, this 
appeared to be most often the case when physical stressors were used, as opposed to 
psychological stressors (compare, table 1.a. and 1.b.). Due to the small number of available 
studies, it is difficult to draw definite conclusion from this finding. Clearly, the rodent PPI 
response is strain, age and gender dependent (Palmer et al., 2000; Swerdlow et al., 2006; 
Pietropaolo & Crusio, 2009), and stress appears to differentially influence PPI across strains 
and sexes (Varty & Geyer, 1998; Faraday et al., 1999). Despite these limitations, it could be 
speculated that psychological stressors may have a higher ethological validity, which could 
produce more pronounced effects on PPI. In this respect, it is interesting to note that the 
stress that is associated with episodes of relapse in schizophrenia patients is often of a 
psychological nature (Walker & Diforio, 1997). However, more studies on the effects of 
different types of stress on PPI are needed to reach a conclusion at this point.  
 
Physical stress 
Subject Intervention Stress-
test 
interval 
PPI Startle P50 Reference 
Human Cold stress 0 n.d. n.d. ↓ Ermutlu et al., 2005; 
Johnson & Adler, 1993 
Rat Cold stress 20 min ↓ = n.d. Leitner, 1986 
Rat Foot-shock 5 days ↑ ↑ n.d. Pijlman et al., 2003 
Rat Foot-shock 0, 24 and 
48 hr, 9 d
= = n.d. Bakshi et al., 2011 
Rat Foot-shock 2 weeks = = n.d. Bijlsma et al., 2009 
Rat Restraint 0 = = n.d. Acri, 1994 
Rat Restraint 5 min  ↓ , = = n.d. Faraday, 2002 
Rat Restraint 30 min ↓  = n.d. Sutherland & Conti, 2011 
Rat Restraint 3 weeks = = n.d. Bijlsma et al., 2009 
Table 1.a Overview of animal and human studies on effects of physical stressors in adult life 
on measures of sensory gating. PPI, prepulse inhibition; P50; P50 wave of event-related 
potential; n.d., not determined; ↑, ↓, =, response is improved, diminished, unchanged, 
respectively, when compared to control conditions.  
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Emotional stress 
Subject Intervention Stress-
test 
interval 
PPI Startle P50 Reference 
Human Mental 
stress 
0 n.d. n.d.  White & Yee, 1997 
Human Attention 
Threat -  
brief        
prolonged  
0 ↑ 
 
↑ 
↓ 
= 
 
↑ 
n.d. 
n.d. Grillon & Davis, 1997 
Rat Threat 
(intense 
light) 
0 ↓ ↑ n.d. Current chapter 
Rat Predator 24 hrs ↓ = n.d. Bakshi et al., 2011 
Rat Predator 0, 46 hrs, 
9 d 
= = n.d. Bakshi et al., 2011 
Rat Novelty 
(light) 
0 ↓ ↓ n.d. Schmajuk et al., 2009 
Mouse  Social defeat 24 hrs ↓ = n.d. Brzozka et al., 2011 
Rat Witness 
stress 
0 = = n.d. Acri, 1994 
Rat Witness 
stress 
5 days = = n.d. Pijlman et al., 2003 
Table 1.b Overview of animal and human studies on effects of emotional stressors in adult 
life on measures of sensory gating. PPI, prepulse inhibition; P50; P50 wave of event-related 
potential; n.d., not determined; ↑, ↓, =, response is improved, diminished, unchanged, 
respectively, when compared to control conditions. 
Based on the available studies, it is suggested that in healthy organisms, alterations in PPI 
induced by acute stress in adulthood are probably reversible, not causing permanent break 
down of gating mechanisms. Considering the neurodevelopmental theory of schizophrenia 
(section 1.3), it may be more etiologically relevant  to apply the experimental stressors in 
early life. Therefore, in the next section, the effects of neurodevelopmental interventions on 
the rodent PPI response will be discussed. 
3. Early-life stress and prepulse inhibition: neurodevelopmental animal 
models 
According to neurodevelopmental theories (section 1.3), schizophrenia is considered a 
developmental disorder, influenced by both genes and the (early) environment. To get 
more insight into the possible role of early risk factors in the development of 
schizophrenia, early-stress paradigms are applied to laboratory rodents. In the following 
section, some common approaches for introducing developmental stress are reviewed, 
with their subsequent impact on PPI in later life. Note that this section does not attempt to 
exhaustively cover all available types of early stress in relevant animal models. The 
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interested reader is referred to more in-depth articles on this topic (Van den Buuse et al., 
2003; Markham & Koenig, 2011).  
3.1 Isolation rearing 
One developmental manipulation that has received particular attention with respect to PPI 
is isolation-rearing. In this procedure, rats or mice are housed in single cages from the time 
of weaning (about 21 days after birth) until adulthood (Bakshi & Geyer, 1999; Varty et al., 
1999; Varty et al., 2006; Pietropaolo et al., 2008), and thereby deprived of social contact with 
their peers during (neuro)development (Einon & Morgan, 1977). In comparison to group-
housed controls, postweaning-isolated rodents exhibit a range of brain and behavioral 
changes, reminiscent to schizophrenia (Powell et al., 2003; Van den Buuse et al., 2003; Harte 
et al., 2007). Several studies have reported PPI deficits in isolation-reared rats (Geyer et al., 
2001) and mice (Varty et al., 2006; Pietropaolo et al., 2008), which could be reversed by 
pretreatment with typical and atypical antipsychotics (Varty & Higgins, 1995). However, 
subsequent studies have indicated that the effect of isolation rearing is strain dependent 
(Weiss et al., 2000), sensitive to housing conditions (Weiss et al., 1999), developmental 
timing (Wilkinson et al., 1994), and could be prevented by handling the isolated rats (Krebs-
Thomson et al., 2001). Moreover, in order to effectively disrupt PPI, isolation rearing has to 
be maintained until the moment of testing (Bakshi & Geyer, 1999; Varty et al., 1999). Based 
on these drawbacks, the validity of isolation rearing as possible animal model for early life 
effects on schizophrenia-related behaviors is considered questionable (Geyer et al., 2001; 
Varty et al., 1999).   
3.2 Maternal separation 
Since rats and mice are born at a more immature stage of development than humans,  
neonatal interventions in these animals are comparable with adverse events in mid-late 
gestation in humans (Van den Buuse et al., 2003). In this respect, maternal separation, being 
a neonatal neurodevelopmental model, differs fundamentally from isolation rearing (see 
previous section), which is a post weaning model. Maternal deprivation, or the temporary 
separation of rodent pups from their mother early in life, leads to various neurochemical 
changes, some with relevance to schizophrenia (Van den Buuse et al., 2003).  
At the behavioral level, a single 24-hours period of maternal deprivation (at postnatal days 6 
or 9) has been shown to induce deficits in PPI in a delayed fashion (i.e. arising after 
puberty), suggesting that certain long-term processes are set in motion by the early 
deprivation (Ellenbroek et al., 1998). These deficits could be reversed by pretreatment with 
typical and atypical antipsychotics (Ellenbroek et al., 1998). The fact that changes in PPI do 
not appear before adulthood, led Ellenbroek and co-workers to investigate whether the 
effect is unavoidable, or rather dependent on manipulations after the deprivation period 
(Ellenbroek & Cools, 2002). First, they combined maternal deprivation with the post 
weaning isolation rearing procedure (see section 3.1.). Surprisingly, whereas both 
procedures were found to reliably disrupt PPI when applied separately, together they had 
no effect. Furthermore, they investigated the role of the mother, as the deprivation 
procedure obviously affects the dam, as well as the pups. To do this, either half of the litters 
were maternally deprived (in this way, the mother had pups to nurse during the 
deprivation period), or maternally deprived mothers were cross fostered to non-deprived 
pups and vice versa. In all cases, the pups displayed small deficits in PPI, compared to fully 
deprived controls, suggesting that the behavior of the mother, and possibly, her milk 
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production, is also affected by the deprivation period. Thus, the authors concluded that the 
post-deprivation period is of crucial importance for the development of prepulse inhibition 
deficits in maternally deprived rats. Also, methodological factors such as timing, duration, 
and number of deprivation episodes, could possibly explain a lack of effect of maternal 
deprivation (Ellenbroek & Cools, 2002). Thereby, the ability of maternal separation to 
produce PPI-disrupting effects appears to be dependent on genetic strain (Ellenbroek & 
Cools, 2000), and species under study (rat vs. mouse) (Millstein & Holmes, 2007; Groenink et 
al., 2011; Naert et al., 2011).  
Thus, maternal separation seems to induce PPI-deficits in a delayed fashion; however, the 
effect could be influenced by various protecting or facilitating post-deprivational factors, 
which might be similar to the influence of early-life stressors in humans.  
3.3 Prenatal maternal immune activation 
Epidemiological, clinical and preclinical studies have provided evidence that gestational 
exposure to certain infections, such as influenza, contributes to the etiology of schizophrenia 
(see Introduction). Similarly, animal models of maternal immune activation have yielded 
behavioral, neurochemical and neurophysiological findings that are consistent with 
observations in schizophrenia patients (Brown & Derkits, 2010). Currently, specific 
candidate infections have been identified that appear to be associated with an increased risk 
of schizophrenia, including rubella, influenza, herpes simplex, toxoplasma gondii, measles, 
polio, and genital and/or reproductive infections (Meyer & Feldon, 2009). A mechanism 
common to the immune response accompanying these infections, is the release of 
inflammatory cytokines. Consequently, elevation of maternal cytokine levels during 
pregnancy is thought to alter the trajectory of brain development, resulting in the induction 
of pathophysiological processes associated with mental illness (Markham & Koenig, 2011). 
Animal models of maternal immune challenge have used different immunogenic agents, all 
inducing a cytokine-associated inflammatory response in the mothers. However, other 
factors could be of relevance as well, for instance, immune activation is associated with 
fever, weight loss and elevated corticosteroids, which might compromise the offspring’s in 
utero metabolic needs, thereby possibly affecting fetal brain development  (Markham & 
Koenig, 2011).  The effects of maternal infection on PPI have been investigated in several 
studies.  
Systemic administration of bacterial endotoxin lipopolysaccharide (LPS) is capable of 
inducing a powerful immune response in the exposed animal, as well as fever and weight 
loss (Markham & Koenig, 2011). While LPS can be detected in both maternal and placental 
tissues, it is not found in the fetus (Ashdown et al., 2006), indicating that LPS itself is not 
responsible for the effects of maternal infection on the fetal brain. Several studies reported 
PPI disruptions in adult rat offspring of LPS infected mothers (Borrell et al., 2002; Fortier et 
al., 2007; Romero et al., 2007; Romero et al., 2010). These PPI deficits were associated with 
changes in dopaminergic transmission, and could be reversed by adult treatment with 
antipsychotics (Borrell et al., 2002; Romero et al., 2007). Interestingly, next to LPS, also 
turpentine, i.e. an inducer of local inflammation, at doses known to produce fever, 
significantly decreased PPI in adult offspring (Fortier et al., 2007). In analogy to the human 
situation, the influence of prenatal human influenza virus exposure on later brain 
development and behavior has been studied. Respiratory infection of pregnant BALB/c and 
C57BL/6 mice with the human influenza virus resulted in various behavioral abnormalities 
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in the adult offspring, among which deficits in PPI, which were sensitive for antipsychotics 
(Shi et al., 2003). In other studies, offspring of similarly infected mice displayed 
morphological and neurochemical changes reminiscent to schizophrenia, although the 
importance of these effects for the PPI deficits is unclear (Van den Buuse et al., 2003). Of 
note, however, is the large reduction in expression of the brain protein reelin in cortex en 
hippocampus (Fatemi et al., 1999), which is associated with both schizophrenia (Guidotti et 
al., 2000) and impaired PPI (Pappas et al., 2001). Lastly, viral infection is simulated in rats 
and mice by polyriboinosinic-polyribocytidilic acid (poly I:C), an agent structurally similar 
to double-stranded RNA, which forms the genetic material of some viruses. While 
administration of poly I:C to pregnant rodents can result in increased levels of cytokines in 
fetal brain, it only generates a non-specific immune response, without particular anti-viral 
antibodies (for references, see Markham & Koenig, 2011). With respect to PPI, treatment of 
pregnant mice or rats with poly I:C generates offspring that shows an impaired PPI 
response from post pubertal age (Ozawa et al., 2006; Li et al., 2009b; Piontkewitz et al., 2009; 
Vuillermot et al., 2010), which is presumably mediated by dopaminergic maldevelopment 
(Ozawa et al., 2006; Vuillermot et al., 2010). 
Thus, animal models of prenatal maternal infection show altered fetal brain development 
and disrupted PPI in adult offspring, probably mediated by the maternal immune response. 
These findings are in line with epidemiologic and clinical investigations on infection as a 
risk factor of schizophrenia (Brown et al., 2010). 
3.4 Multiple stressors 
Based on the two-hit hypothesis of schizophrenia (see Introduction), several experimental 
animal studies have applied multiple interventions at different stages of development, to 
investigate their combined influence on schizophrenia-like behaviors. Possibly, this method 
may give additional mechanistic insights compared to single interventions alone. In the 
remaining part of this section, studies addressing the combined effects of multiple 
interventions on PPI will be discussed. 
In one study, the interaction between stress and dopaminergic regulation of PPI was 
investigated (Choy & van den Buuse, 2008; Choy et al., 2009). After combining two 
subsequent stressors in neonatal and young-adult life (i.e., maternal deprivation and 
prolonged corticosterone treatment, respectively), PPI was tested in rats following acute 
injections with apomorphine. In controls and in rats that had undergone either one of the 
two stressors, the apomorphine treatment was found to disrupt PPI, while in the group that 
had experienced the multiple stress, no PPI-disruptions were observed in response to 
apomorphine (Choy & van den Buuse, 2008). According to the authors, their findings 
implicate an inhibitory interaction of early and late developmental stress, on dopaminergic 
regulation of PPI (Choy & van den Buuse, 2008). In a follow-up study, the authors suggested 
that this inhibitory interaction may be caused by receptor desensitization, because no 
changes were found in levels of dopamine D1 and D2 receptors (Choy et al., 2009). Notably, 
the finding that a subsequent stressor could reverse PPI-disruptive effects of a particular 
stressor, has been reported elsewhere (i.e., maternal separation and isolation rearing, 
(Ellenbroek & Cools, 2002). The above-mentioned experiments are in line with the idea that 
glucocorticoids could affect PPI by modulation of dopaminergic systems (see section 2.2.). 
In most studies addressing the two-hit hypothesis, the first hit comprises a genetic 
predisposition. Consequently, it is investigated how genes interact with early stress to 
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produce schizophrenia-like neurochemical and behavioral alterations. As the focus of this 
chapter lies on the effects of stress on PPI, we will not discuss the neurochemical findings 
from genetic animal models of schizophrenia. Genotypes that have been found to interact 
with early stress to influence PPI include, nuclear receptor Nurr1 heterozygosity (i.e., 12 
weeks of isolation rearing – Eells et al., 2006), Snap-25 mouse mutant blind-drunk (i.e., 
variable prenatal stress – Oliver & Davies, 2009), and NMDA receptor hypofunction mouse 
mutant (predation stress – Duncan et al., 2004). Notably, the latter study made use of 
predator olfactory cues (i.e., rat odor), which normalized the reduced PPI that was observed 
under control conditions in male mutants only. This result is in contrast to the study of 
Bakshi (section 2.1.3.), where predator exposure was found to decrease PPI in rats. However, 
an important methodological difference should be noted. Bakshi and co-workers actually 
introduced a predator in their experiment, while Duncan et al. only exposed the animals to 
predator odor. This difference in approach might have implications for the level of threat 
perceived by the subjects. In particular, when solely olfactory cues signal predation risk, 
perceiving animals may become more vigilant, which is thought to facilitate processing of 
sensory stimuli, possibly increasing PPI. Proximal presence of the predator, on the other 
hand, is likely to represent a severe stressor, which may induce disruptions in PPI due to 
progressive loss of sensory perception (see section 2.4.). Possibly, the delayed stress effect 
observed in the Bakshi study could be accounted for by recruitment of central mediators of 
the stress response, such as CRF.   
In conclusion, although limited, the studies mentioned in this section suggest that 
combining multiple stressors, or a genetic vulnerability and stress, may induce stronger 
alterations in sensorimotor gating, when compared to one single intervention. Further 
relevant studies are warranted to test this hypothesis.  
4. General conclusions 
In this chapter, we have discussed studies that investigated the association between 
experience of stress and PPI, the latter being a highly validated model for schizophrenia; a 
mental disorder that is thought to be caused by an interaction of a constitutional 
vulnerability with environmental stress (see Introduction). From both animal and human 
studies, it is found that – by an unknown mechanism – application of acute stressors in 
adulthood is able to affect PPI, at least, transiently (table 1). Possibly, on the short term, 
moderate threat or attention to the environment could facilitate processing of sensory 
stimuli via elevated cortical arousal, leading to increased information processing; while 
severe or prolonged stressors may cause progressive loss of sensory perception that 
functions to reduce the impact of impending aversive events (section 2.4.). These perceptual 
deteriorations may be mediated by, for instance, cortisol- and CRF-induced activation of the 
mesolimbic dopamine system, a neural system that is implicated in both stress responsivity 
and PPI. Also, it is suggested that alterations in PPI induced by the acute stressors under 
study are probably reversible, not causing permanent changes to brain structures important 
in the regulation of PPI. These results are in line with clinical and epidemiological findings, 
which suggest that experience of stressful life events does not trigger onset of psychotic 
illness in healthy individuals (see Introduction). However, clearly, the acute and chronic 
stressors applied in the laboratory do not mimic ‘naturally occurring’ transient stress in the 
real world. This type of stress may come and go, and, depending on how long it stays, it 
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could ultimately cause permanent alterations in brain systems associated with psychosis in 
vulnerable individuals, as was observed in longitudinal studies (reviewed by Phillips et al., 
2007; Walker et al., 2008). 
The clinical observation that schizophrenia generally does not manifest until the third 
decade of life, suggests that it is the final outcome of pathological processes acting on the 
immature brain, and accordingly, it has led to formulation of the neurodevelopmental 
theory for the etiology of schizophrenia (see Introduction). In order to get more insight into 
the possible role of early environmental risk factors in illness development, early-stress 
paradigms are applied to rodents. Some developmental manipulations that have been 
shown to affect adult PPI include isolation rearing, maternal separation, and prenatal 
maternal immune activation (section 3). An alternative hypothesis within the framework of 
the neurodevelopmental theory of schizophrenia is referred to as the two-hit model. 
According to this model, early and late risk factors are not simply additive, but instead, the 
first hit will increase an individual’s vulnerability for effects of a subsequent hit (see 
Introduction). Based on this theory, a few animal studies have applied multiple 
interventions at subsequent stages of development, to study their combined impact on 
schizophrenia-like behaviors, including PPI.  Interestingly, although limited, results so far 
do not support the theory. Rather, instead of an augmentation, an inhibitory interaction of 
early and later developmental stress has been reported by two independent research 
groups. On the other hand, several studies have successfully identified candidate genes that 
could contribute to the induction of schizophrenia-like phenotypes in interaction with stress 
(section 3.4.). Possibly, investigating the interaction of these candidate genes with 
experimental stressors in animal studies, could represent a fruitful approach to model the 
link between stress and schizophrenia.   
In humans, it is known that a wide variation exists in response to adversity, with some 
individuals being more stress-sensitive than others, and some individuals being more prone 
to developing an illness in response to environmental adversity than others (Kendler et al., 
2005). Attempts have been made to explain the source of this variation; several studies have 
investigated the link between genetic polymorphisms and environmental stress in the 
etiology of schizophrenia. Some progress has been made, for instance, a recent genome-wide 
association study – contrasting large numbers of genetic variants in patients and controls – 
revealed significant associations between schizophrenia and polymorphisms in major 
histocompatibility complex (MHC), a region implicated in the bodily reactions to stress and 
infection (Stefansson et al., 2009). Also, although not yet replicated, the novel schizophrenia 
risk polymorphism ZNF804A was found to be associated with increased prefrontal-
hippocampal and prefrontal-amygdala connectivity, possibly linking to increased sensitivity 
to stressful environments (Esslinger et al., 2009). In another study, the association between a 
serotonin transporter gene polymorphism (i.e. 5-HTTLPR), stress and disease characteristics 
was investigated in individuals diagnosed with psychotic disease (Goldberg et al., 2009). 
Therefore, symptoms occurring in the four-week period preceding hospitalization were 
evaluated in first-onset patients. As a result, stress (i.e. negative life-events preceding 
hospitalization) was found to be a predictor of depressive symptoms, but it did not interact 
with psychotic (or negative) symptoms. Together, the above-mentioned studies have 
genetically linked schizophrenia with several systems/brain structures important in stress 
regulation (e.g., MHC, amygdala, PFC). However, so far, no experimental studies have 
linked this gene-environment interaction with schizophrenia, which is probably caused by 
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the fact that schizophrenia is a complex disorder, putatively determined by the sum of 
numerous small effects of individual genes; hence the importance of using endophenotypes 
such as PPI in association studies.   
In conclusion, the link between stress and PPI appears to be in line with 
neurodevelopmental theories of schizophrenia; a single stressor in adult life does not seem 
to cause lasting alterations in PPI, however, when applied during a critical stage of 
neurodevelopment or in genetically vulnerable organisms, stress could be more powerful in 
robustly affecting PPI. It is suggested, that future animal studies aimed at investigating the 
role of stress in the development of information processing dysfunctions in schizophrenia, 
may benefit from implementing human risk gene polymorphisms that are associated with 
stress (e.g. by making use of inducible transgenic mouse models). 
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